Ticker Symbol: PROC
Procaps Group S.A
$9.90 - 02-12-2024 4 p.m. ET
Exchange: NASDAQ
Currency:
USD
Asset
Type: Common Stock
CIK:0001863362
Company Profile
Procaps is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies that reach more than 50 countries in all five continents. Procaps has a direct presence in 13 countries in Latin America and, as of December 31, 2020, had more than 4,700 collaborators working under a sustainable model. Procaps develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements and high-potency clinical solutions.
Sector: Manufacturing
Industry: Medicinal and Botanical Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: N/A
Website: www.procapsgroup.com
CEO: N/A
Tags:
N/A
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $3.56
Change:
-$0.03
(
-0.84%)
Days Range: $3.53 - $3.79
Beta: -
52wk. High: $7.75
52wk. Low: $2.09
Ytd. Change -32.46%
50 Day Moving Average: $3.38
200 Day Moving Average: $4.05
Shares Outstanding: 112824183
Valuation
Market Cap: 40.2B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A